Khoshsokhan, Sina. The Costs They Are a-Rising: Commercialization Costs and the Innovation Process in Drug Development. Academy of Management Annual Meeting Proceedings. 2024, Vol. 2024 Issue 1, p1-6.

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...

As artificial intelligence begins to play a more central role in drug discovery, how do researchers and scientists achieve the right mix of AI-driven insights, data integrity, human involvement and ...

There are over 600,000 drugs in the Korea Chemical Bank. It was daunting to find the right one that fits the protein structure we’re targeting. That’s when I thought of AI and contacted Daewoong ...

While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using generative artificial intelligence could vastly ...

Tariff pressures, a changing regulatory environment, and risk-averse investors have left many Cambridge biotechnology ...

Artificial Intelligence has an exciting future in health care, from streamlining insurance claims, to aiding radiologists, dermatologists, cardiologists and other specialties by enhancing data-based ...

Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product ...